Overview

Observational Non-interventional Study (Anwendungsbeobachtung) With AptivusĀ® (Tipranavir) in HIV-infected Patients.

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This observational study is supposed to assess (under conditions of clinical practice in daily routine) whether treatment with Aptivus (tipranavir) in combination with low-dose Norvir (ritonavir) will durably suppress viral load and may achieve suppression of viral load below the limit of detection.
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Ritonavir
Tipranavir